Bispecific Antibody and Chelator Preparation

The BsAb and CA were prepared according to reported methods (19 (link),21 (link)). DOTA-Bn was obtained commercially (Macrocyclics, Plano, TX) and used without any additional purification.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Chandler C.S., Bell M.M., Chung S.K., Veach D.R., Fung E.K., Punzalan B., Vargas D.B., Patel M., Xu H., Guo H.F., Santich B.H., Zanzonico P.B., Monette S., Nash G.M., Cercek A., Jungbluth A., Pandit-Taskar N., Cheung N.K., Larson S.M, & Cheal S.M. (2021). Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis. Molecular cancer therapeutics, 21(1), 125-137.

Publication 2021

DOTA-Bn

Dota

Corresponding Organization : Memorial Sloan Kettering Cancer Center

Other organizations : Cornell University, Rockefeller University

Top 5 similar protocols

Variable analysis

independent variables

Preparation of BsAb and CA according to reported methods (19 and 21)

dependent variables

Not explicitly mentioned

control variables

DOTA-Bn obtained commercially (Macrocyclics, Plano, TX) and used without any additional purification

controls

Positive control: Not mentioned
Negative control: Not mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!